Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33882206

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Apr 22
First author
Bardia A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Jun;18(6):322. doi: 10.1038/s41571-021-00516-x.
    note
    Source null
    related pmid
    33931767
    relationship
    Comment in
  2. citation
    N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478.
    note
    Source null
    related pmid
    34260847
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2021 Jul;9(14):1113. doi: 10.21037/atm-21-1103.
    note
    Source null
    related pmid
    34430554
    relationship
    Comment in
  4. citation
    Future Oncol. 2021 Oct 1;17(30):3911-3924. doi: 10.2217/fon-2021-0868.
    note
    Source null
    related pmid
    34467774
    relationship
    Comment in
  5. citation
    Ann Transl Med. 2022 Apr;10(7):389. doi: 10.21037/atm-21-6999.
    note
    Source null
    related pmid
    35530936
    relationship
    Comment in
  6. citation
    Ann Transl Med. 2022 Apr;10(7):390. doi: 10.21037/atm-22-484.
    note
    Source null
    related pmid
    35530962
    relationship
    Comment in
  7. citation
    Ann Transl Med. 2022 Jun;10(11):647. doi: 10.21037/atm-22-813.
    note
    Source null
    related pmid
    35813338
    relationship
    Comment in
  8. citation
    Ann Transl Med. 2022 May;10(9):501. doi: 10.21037/atm-22-621.
    note
    Source null
    related pmid
    35928735
    relationship
    Comment in
  9. citation
    Ann Transl Med. 2022 Sep;10(18):1031. doi: 10.21037/atm-22-1892.
    note
    Source null
    related pmid
    36267779
    relationship
    Comment in
  10. citation
    Ann Transl Med. 2022 Nov;10(21):1184. doi: 10.21037/atm-22-4581.
    note
    Source null
    related pmid
    36467370
    relationship
    Comment in

Authors and identifiers

  1. name
    Bardia A
    type
    Author
  2. name
    Hurvitz SA
    type
    Author
  3. name
    Tolaney SM
    type
    Author
  4. name
    Loirat D
    type
    Author
  5. name
    Punie K
    type
    Author
  6. name
    Oliveira M
    type
    Author
  7. name
    Brufsky A
    type
    Author
  8. name
    Sardesai SD
    type
    Author
  9. name
    Kalinsky K
    type
    Author
  10. name
    Zelnak AB
    type
    Author
  11. name
    Weaver R
    type
    Author
  12. name
    Traina T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Bardia A
    type
    Author
  2. name
    Hurvitz SA
    type
    Author
  3. name
    Tolaney SM
    type
    Author
  4. name
    Loirat D
    type
    Author
  5. name
    Punie K
    type
    Author
  6. name
    Oliveira M
    type
    Author
  7. name
    Brufsky A
    type
    Author
  8. name
    Sardesai SD
    type
    Author
  9. name
    Kalinsky K
    type
    Author
  10. name
    Zelnak AB
    type
    Author
  11. name
    Weaver R
    type
    Author
  12. name
    Traina T
    type
    Author
bibliography ids
  1. nci-bib-3f13e3fa450ae1ea3661c030
book metadata
content sha256
dbe87464144f414d48144da572a55660ba347e6659dd4595769316df7d09d986
document type
citation
dois
  1. 10.1056/NEJMoa2028485
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33882206
immutable id
pubmed:33882206@dbe87464144f414d48144da572a55660ba347e6659dd4595769316df7d09d986
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
16
name
The New England journal of medicine
nlm unique id
0255562
pages
1529-1541
volume
384
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Jun;18(6):322. doi: 10.1038/s41571-021-00516-x.
    note
    Source null
    related pmid
    33931767
    relationship
    Comment in
  2. citation
    N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478.
    note
    Source null
    related pmid
    34260847
    relationship
    Comment in
  3. citation
    Ann Transl Med. 2021 Jul;9(14):1113. doi: 10.21037/atm-21-1103.
    note
    Source null
    related pmid
    34430554
    relationship
    Comment in
  4. citation
    Future Oncol. 2021 Oct 1;17(30):3911-3924. doi: 10.2217/fon-2021-0868.
    note
    Source null
    related pmid
    34467774
    relationship
    Comment in
  5. citation
    Ann Transl Med. 2022 Apr;10(7):389. doi: 10.21037/atm-21-6999.
    note
    Source null
    related pmid
    35530936
    relationship
    Comment in
  6. citation
    Ann Transl Med. 2022 Apr;10(7):390. doi: 10.21037/atm-22-484.
    note
    Source null
    related pmid
    35530962
    relationship
    Comment in
  7. citation
    Ann Transl Med. 2022 Jun;10(11):647. doi: 10.21037/atm-22-813.
    note
    Source null
    related pmid
    35813338
    relationship
    Comment in
  8. citation
    Ann Transl Med. 2022 May;10(9):501. doi: 10.21037/atm-22-621.
    note
    Source null
    related pmid
    35928735
    relationship
    Comment in
  9. citation
    Ann Transl Med. 2022 Sep;10(18):1031. doi: 10.21037/atm-22-1892.
    note
    Source null
    related pmid
    36267779
    relationship
    Comment in
  10. citation
    Ann Transl Med. 2022 Nov;10(21):1184. doi: 10.21037/atm-22-4581.
    note
    Source null
    related pmid
    36467370
    relationship
    Comment in
outcomes validated
false
pmid
33882206
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
296b9736c8e1bdc0535c75ca0cefd62d3d0b5b50461c5d8cfe80affd5114aca4
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Apr 22
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33882206/
title
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

Preserved source evidence · Not medical advice